FR1603M - Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6. - Google Patents

Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6.

Info

Publication number
FR1603M
FR1603M FR879115A FR879115A FR1603M FR 1603 M FR1603 M FR 1603M FR 879115 A FR879115 A FR 879115A FR 879115 A FR879115 A FR 879115A FR 1603 M FR1603 M FR 1603M
Authority
FR
France
Prior art keywords
analeptic
cardiotonic
pyridoxine
camphor
possessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR879115A
Other languages
English (en)
Inventor
Georges Kouchner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGROLOGIQUE FRANCAISE SOC
Original Assignee
AGROLOGIQUE FRANCAISE SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AGROLOGIQUE FRANCAISE SOC filed Critical AGROLOGIQUE FRANCAISE SOC
Priority to FR879115A priority Critical patent/FR1603M/fr
Priority to DE19621470220 priority patent/DE1470220A1/de
Priority to GB3146162A priority patent/GB1008165A/en
Application granted granted Critical
Publication of FR1603M publication Critical patent/FR1603M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR879115A 1961-08-21 1961-11-16 Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6. Active FR1603M (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR879115A FR1603M (fr) 1961-08-21 1961-11-16 Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6.
DE19621470220 DE1470220A1 (de) 1961-08-21 1962-08-13 Verfahren zur Herstellung eines Salzes einer von Kampfer hergeleiteten Saeure und einer Base
GB3146162A GB1008165A (en) 1961-08-21 1962-08-16 New organic compounds derived from camphor and pyridoxine which are cardiotonics, respiratory and vascular analeptics, blood-pressure regulators and have the properties of vitamin b6, and process for their production

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR871180 1961-08-21
FR879115A FR1603M (fr) 1961-08-21 1961-11-16 Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6.

Publications (1)

Publication Number Publication Date
FR1603M true FR1603M (fr) 1962-12-10

Family

ID=8761501

Family Applications (2)

Application Number Title Priority Date Filing Date
FR871180A Expired FR1563604A (fr) 1961-08-21 1961-08-21
FR879115A Active FR1603M (fr) 1961-08-21 1961-11-16 Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR871180A Expired FR1563604A (fr) 1961-08-21 1961-08-21

Country Status (2)

Country Link
US (1) US3255197A (fr)
FR (2) FR1563604A (fr)

Also Published As

Publication number Publication date
US3255197A (en) 1966-06-07
FR1563604A (fr) 1969-04-18

Similar Documents

Publication Publication Date Title
Searles Phases of patient-therapist interaction in the psychotherapy of chronic schizophrenia.
Bowlby Disruption of affectional bonds and its effects on behavior.
Von Neumann et al. Theory of games and economic behavior, 2nd rev
DK114131B (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf.
Goldfarb Psychotherapy of the aged: the use and value of an adaptational frame of reference.
NL142681B (nl) Werkwijze voor de bereiding van ademhalingsstimulerende derivaten van s-triazine, werkwijze voor de bereiding van ademhalingsstimulerende preparaten en gevormde ademhalingsstimulerende preparaten, verkregen volgens deze werkwijze.
FR1603M (fr) Nouveaux médicaments dérivés du camphre et de la pyridoxine cardiotoniques, analeptiques, respiratoires et vasculaires, régulateurs de la pression sanguine et possédant les propriétés de la vitamine b6.
DK111632C (da) Apparat til behandling af bronchiektasis og andre sygdomstilstande, hvor der findes væske eller slim i patientens luftveje.
Harriman Twentieth century psychology: recent developments in psychology.
FR1056M (fr) Produit pharmaceutiqué destine au traitement des affections circulatoires des membres supérieurs ou inférieurs.
FR1304766A (fr) Dispositif, notamment pour l'assemblage et le raccordement d'éléments tubulaires ainsi que les clayonnages, rayonnages, ossatures, obtenus par le dispositif conforme à l'invention
Breed et al. " Touch me, like me": Artifact?
FR2576M (fr) Nouveau médicament notamment pour le traitement des troubles de la coagulabilité sanguine.
Baker Introduction to exceptional children, Rev
USD145265S (en) Design for an earring or similar article
FR2117727A1 (en) Sodium naringine - for increasing capillary resistance and impermeability
FR1829M (fr) Nouveau médicament notamment pour le traitement des troubles de la coagulabilité sanguine.
Hahn 1940 followed up.
USD141703S (en) Design for a chair frame or the like
FR1268513A (fr) Procédé pour l'incorporation de graisse à de la poudre de lait, notamment pour laréalisation d'un aliment artificiel
Otsuka et al. The Treatments and Their Results of Compound Fractures of the Leg in Recent Two Years
FR3392M (fr) Médicament dermatologique, notamment pour le traitement de l'eczéma suintant.
Podolsky The vitamin of fertility.
FR1121M (fr) Associations médicamenteuses comportant le formaldéhyde sulfoxylate de sodium et l'isoniazide, destinées aux traitements de la tuberculose et de la lepre.
Fluegelman et al. Experimental treatment of depression with anafranil (Monochlorimipramine).